EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Biosynthesis of Antifungal Solanimycin May Involve an Iterative Nonribosomal Peptide Synthetase Module

Annabel C Murphy, Matthew Corney, Rita E Monson, Miguel A Matilla, George P C Salmond, Finian J Leeper iD

ACS Chemical Biology · 2023

DOI: 10.1021/acschembio.2c00947 ↗

At a glance

Journal article in ACS Chemical Biology, 2023. Written by Annabel C Murphy and 5 co-authors. Institution: Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K. Major MEDLINE topics: Antifungal Agents, Peptide Synthases. Cited 9 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY 4.0). Funded by: Biotechnology and Biological Sciences Research Council, FP7 People: Marie-Curie Actions, Agencia Estatal de Investigación.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Dickeya solani, a plant-pathogenic bacterium, produces solanimycin, a potent hybrid polyketide/nonribosomal peptide (PKS/NRPS) anti-fungal compound. The biosynthetic gene cluster responsible for synthesis of this compound has been identified. Because of instability, the complete structure of the compound has not yet been elucidated, but LC-MS2 identified that the cluster produces two main compounds, solanimycin A and B, differing by a single hydroxyl group. The fragmentation pattern revealed that the central part of solanimycin A is a hexapeptide, Gly-Dha-Dha-Dha-Dha-Dha (where Dha is dehydroalanine). This is supported by isotopic labeling studies using labeled serine and glycine. The N-terminal group is a polyketide-derived C16 acyl group containing a conjugated hexaene, a hydroxyl, and an amino group. The additional hydroxyl group in solanimycin B is on the α-carbon of the glycine residue. The incorporation of five sequential Dha residues is unprecedented because there is only one NRPS module in the cluster that is predicted to activate and attach serine (which is subsequently dehydrated to Dha), meaning that this NRPS module must act iteratively. While a few other iterative NRPS modules are known, they all involve iteration of two or three modules. We believe that the repetitive use of a single module makes the solanimycin biosynthetic pathway unique among NRPSs so far reported.

Subjects

MeSH terms (MEDLINE)

Antifungal AgentsPeptide SynthasesMultigene FamilyPolyketide SynthasesButyric AcidPolyketides

Substances

Antifungal AgentsPeptide SynthasesPolyketide Synthasesnon-ribosomal peptide synthasesolanimycinButyric AcidPolyketides

Authors and institutions

  • Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.
  • Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, U.K.

ORCID profiles: Finian J Leeper

Funding

  • Biotechnology and Biological Sciences Research Council
  • FP7 People: Marie-Curie Actions
  • Agencia Estatal de Investigación

Cite

APA

Murphy, A. C., Corney, M., Monson, R. E., Matilla, M. A., Salmond, G. P. C., & Leeper, F. J. (2023). Biosynthesis of Antifungal Solanimycin May Involve an Iterative Nonribosomal Peptide Synthetase Module. ACS Chemical Biology. https://doi.org/10.1021/acschembio.2c00947

Vancouver

Murphy AC, Corney M, Monson RE, Matilla MA, Salmond GPC, Leeper FJ. Biosynthesis of Antifungal Solanimycin May Involve an Iterative Nonribosomal Peptide Synthetase Module. ACS Chemical Biology. 2023. doi:10.1021/acschembio.2c00947

BibTeX
@article{Murphy2023,
  author = {Murphy, Annabel C and Corney, Matthew and Monson, Rita E and Matilla, Miguel A and Salmond, George P C and Leeper, Finian J},
  title = {Biosynthesis of Antifungal Solanimycin May Involve an Iterative Nonribosomal Peptide Synthetase Module},
  journal = {ACS Chemical Biology},
  year = {2023},
  doi = {10.1021/acschembio.2c00947}
}
Start for free →